Impact of matched related donor transplantation on survival of patients in the low-, intermediate-, or high-risk groups (intent-to-treat analysis). OS and RFS of CN-AML patients according to related donor availability for patients assigned to low-risk (A-B), intermediate-risk (C-D), or high-risk (E-F) groups (2-sided log-rank test).